Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of potential common shares

v3.22.2.2
Net Loss Per Share (Details) - Schedule of potential common shares - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 126,571,874 43,100,000 126,571,874 80,722,625
Conversion of Convertible Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents [1] 25,655,579   25,655,579  
Warrants to Purchase Common Stock and Redeemable Convertible Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents [1] 25,599,889 25,600,000 25,599,889 25,600,000
PSUs, RSUs and Options to Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents [1] 57,816,406   57,816,406 37,622,625
Right to Receive Earnout Shares [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 17,500,000 17,500,000 17,500,000 17,500,000
[1] Prior period results have been adjusted to reflect the exchange of Legacy MoneyLion Common Stock for MoneyLion Class A Common Stock at the Exchange Ratio of approximately 16.4078 in September 2021 as a result of the Business Combination. See Note 3, “Business Combination” for details.